epoetin alfa,luspatercept
bms
['epoetin', 'mds', 'lusp']
luspatercept appears more effective than epoetin alfa for treating anemia in patients with esa-na ve, transfusion-dependent, lower-risk mds, according to research presented at asco 2023. #asco23 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.